Cargando…

Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression

Anti-angiogenic therapies for melanoma have not yet been translated into meaningful clinical benefit for patients, due to the development of drug-induced resistance in cancer cells, mainly caused by hypoxia-inducible factor 1α (HIF-1α) overexpression and enhanced oxidative stress mediated by tumor-a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rauca, Valentin-Florian, Patras, Laura, Luput, Lavinia, Licarete, Emilia, Toma, Vlad-Alexandru, Porfire, Alina, Mot, Augustin Catalin, Rakosy-Tican, Elena, Sesarman, Alina, Banciu, Manuela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585864/ https://www.ncbi.nlm.nih.gov/pubmed/34764332 http://dx.doi.org/10.1038/s41598-021-01284-5

Ejemplares similares

Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cells
por: Rauca, Valentin-Florian, et al.
Publicado: (2018)

Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis
por: Negrea, Giorgiana, et al.
Publicado: (2022)

Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5‐fluorouracil in vivo
por: Luput, Lavinia, et al.
Publicado: (2020)

Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment
por: Licarete, Emilia, et al.
Publicado: (2020)

In Vivo Double Targeting of C26 Colon Carcinoma Cells and Microenvironmental Protumor Processes Using Liposomal Simvastatin
por: Luput, Lavinia, et al.
Publicado: (2018)

A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy
por: Barbălată, Cristina Ioana, et al.
Publicado: (2021)

Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach
por: Tefas, Lucia Ruxandra, et al.
Publicado: (2017)

Trojan horse treatment based on PEG-coated extracellular vesicles to deliver doxorubicin to melanoma in vitro and in vivo
por: Patras, Laura, et al.
Publicado: (2021)

A quality by design approach for the development of lyophilized liposomes with simvastatin
por: Porfire, Alina, et al.
Publicado: (2017)

Biologically Active Ajuga Species Extracts Modulate Supportive Processes for Cancer Cell Development
por: Rauca, Valentin-Florian, et al.
Publicado: (2019)

The Use of the QbD Approach to Optimize the Co-Loading of Simvastatin and Doxorubicin in Liposomes for a Synergistic Anticancer Effect
por: Barbalata, Cristina-Ioana, et al.
Publicado: (2022)

Normoxic Tumour Extracellular Vesicles Modulate the Response of Hypoxic Cancer and Stromal Cells to Doxorubicin In Vitro
por: Patras, Laura, et al.
Publicado: (2020)

An Electrochemical Strategy for the Simultaneous Detection of Doxorubicin and Simvastatin for Their Potential Use in the Treatment of Cancer
por: Rus, Iulia, et al.
Publicado: (2021)

An Overview of the Supramolecular Systems for Gene and Drug Delivery in Tissue Regeneration
por: Ranamalla, Saketh Reddy, et al.
Publicado: (2022)

The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent—DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors
por: Drzyzga, Alina, et al.
Publicado: (2021)

Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy
por: Zhao, Ting, et al.
Publicado: (2022)

Codelivery of Chemotherapeutics via Crosslinked Multilamellar Liposomal Vesicles to Overcome Multidrug Resistance in Tumor
por: Liu, Yarong, et al.
Publicado: (2014)

Codelivery of Doxorubicin and Paclitaxel by Cross-Linked Multilamellar Liposome Enables Synergistic Antitumor Activity
por: Liu, Yarong, et al.
Publicado: (2014)

Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy
por: Bi, Ye, et al.
Publicado: (2018)

Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma
por: Zhang, Yue, et al.
Publicado: (2017)

The effect of UV light on division capacity of Helianthus mollis L. protoplasts
por: vesa, Simona, et al.
Publicado: (2005)

Targeted Codelivery of Prodigiosin and Simvastatin Using Smart BioMOF: Functionalization by Recombinant Anti-VEGFR1 scFv
por: Mirzaeinia, Somayyeh, et al.
Publicado: (2022)

Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery
por: Zheng, Zening, et al.
Publicado: (2020)

Testing the Limits of a Portable NIR Spectrometer: Content Uniformity of Complex Powder Mixtures Followed by Calibration Transfer for In-Line Blend Monitoring
por: Casian, Tibor, et al.
Publicado: (2021)

The Synergistic Antitumor Effect of 5-Fluorouracil Combined with Allicin against Lung and Colorectal Carcinoma Cells
por: Țigu, Adrian Bogdan, et al.
Publicado: (2020)

Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects
por: Jiang, Hong, et al.
Publicado: (2019)

Effect of Chitosan and Liposome Nanoparticles as Adjuvant Codelivery on the Immunoglobulin G Subclass Distribution in a Mouse Model
por: Haryono, Agus, et al.
Publicado: (2017)

Dual-Functional Peptide Driven Liposome Codelivery System for Efficient Treatment of Doxorubicin-Resistant Breast Cancer
por: Ahmed, Kamel S, et al.
Publicado: (2021)

Protective Effect of Liposomal Epigallocatechin-Gallate in Experimental Gentamicin-Induced Hepatotoxicity
por: Bulboacă, Adriana Elena, et al.
Publicado: (2022)

Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
por: Chang, Jiajia, et al.
Publicado: (2023)

Passive transfer of collagen XVII-specific antibodies induces sustained blistering disease in adult mice
por: Chiriac, Mircea Teodor, et al.
Publicado: (2013)

Curcumin-Loaded Microspheres Are Effective in Preventing Oxidative Stress and Intestinal Inflammatory Abnormalities in Experimental Ulcerative Colitis in Rats
por: Hales, Dana, et al.
Publicado: (2022)

Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer
por: Li, Longxia, et al.
Publicado: (2022)

Phytochemical Analysis and In Vitro Effects of Allium fistulosum L. and Allium sativum L. Extracts on Human Normal and Tumor Cell Lines: A Comparative Study
por: Țigu, Adrian Bogdan, et al.
Publicado: (2021)

Codelivery of a cytotoxin and photosensitiser via a liposomal nanocarrier: a novel strategy for light-triggered cytosolic release
por: Yaghini, Elnaz, et al.
Publicado: (2018)

Liposomal Curcumin Enhances the Effect of Naproxen in a Rat Model of Migraine
por: Bulboacă, Adriana E., et al.
Publicado: (2019)

The effect of intravenous administration of liposomal curcumin in addition to sumatriptan treatment in an experimental migraine model in rats
por: Bulboacă, Adriana E, et al.
Publicado: (2018)

Liposomal Curcumin is Better than Curcumin to Alleviate Complications in Experimental Diabetic Mellitus
por: Bulboacă, Adriana Elena, et al.
Publicado: (2019)

The chemotherapeutic agent DMXAA potently and specifically activates the TBK1–IRF-3 signaling axis
por: Roberts, Zachary J., et al.
Publicado: (2007)

Dissection of stromal and cancer cell-derived signals in melanoma xenografts before and after treatment with DMXAA
por: Henare, K, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n6hrokt28tqagk82joarn5i1u6